APA

Chaudhary N. K., John R. R., Boddu D., Mahasampath G., Nesadeepam N. & Mathew L. G. (20191213). Palonosetron is a Better Choice Compared With Ondansetron for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in a Resource-limited Pediatric Oncology Center: Results From a Randomized Control Trial. : Journal of pediatric hematology/oncology.

Chicago

Chaudhary Narendra K, John Rikki R, Boddu Deepthi, Mahasampath Gowri, Nesadeepam Nalini and Mathew Leni G. 20191213. Palonosetron is a Better Choice Compared With Ondansetron for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in a Resource-limited Pediatric Oncology Center: Results From a Randomized Control Trial. : Journal of pediatric hematology/oncology.

Harvard

Chaudhary N. K., John R. R., Boddu D., Mahasampath G., Nesadeepam N. and Mathew L. G. (20191213). Palonosetron is a Better Choice Compared With Ondansetron for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in a Resource-limited Pediatric Oncology Center: Results From a Randomized Control Trial. : Journal of pediatric hematology/oncology.

MLA

Chaudhary Narendra K, John Rikki R, Boddu Deepthi, Mahasampath Gowri, Nesadeepam Nalini and Mathew Leni G. Palonosetron is a Better Choice Compared With Ondansetron for the Prevention of Chemotherapy-induced Nausea and Vomiting (CINV) in a Resource-limited Pediatric Oncology Center: Results From a Randomized Control Trial. : Journal of pediatric hematology/oncology. 20191213.